Aragn F, Karaca M, Novials A, Maldonado R, Maechler P, Rub B
10.1016/S0002-9440(10)64058-8 Am
Common adverse effects of GLP-1 receptor agonists include: Gastrointestinal symptoms (nausea, vomiting, diarrhoea, constipation)usually mild to moderate and often diminishing over time Injection site reactions Headache Fatigue More serious but rare adverse effects have been identified, including: Pancreatitis patients should seek urgent medical advice for severe, persistent abdominal pain (with or without vomiting) Gallbladder disease symptoms include upper right abdominal pain and jaundice Diabetic retinopathy complications particularly with rapid HbA1c reduction in patients with pre-existing retinopathy Dehydration and acute kidney injury from persistent gastrointestinal symptoms When combined with sulfonylureas or insulin, GLP-1 receptor agonists increase the risk of hypoglycaemia
So the batch was mo good Me encant la verdad seguir comprndolo ya que mi metabolismo y energa los he recuperado
SUPPORTS APPETITE AND METABOLIC FUNCTION Tirzepatide activates both GLP-1 and GIP receptors
Growth hormonereleasing hormone: structure, function, and regulation
